Duke received a $28 Million grant from the NIH to discover immunologic research directed at tackling major scientific problems that hinder the development of an effective HIV-1 vaccine. The vaccine strategy will be based on identifying and targeting novel HIV-1 vulnerabilities to B, T and NK cell immune responses and then using this information to design vaccines that will induce protective immunity at the time and location of HIV-1 transmission.Read More
DefeatHIV, an initiative based out of the Fred Hutchinson Cancer Research Center in Seattle, WA, has been researching potential cures for HIV over the past 5 years. Their research has focused on the use of blood cells genetically modified to be resistant to the HIV virus. It was recently announced that the National Institutes of Health (NIH) awarded the DefeatHIV team a new grant of $23.5 million that will continue to support their research on this potential cure for an additional 5 years.Read More
Since its emergence in the 1980's, HIV/AIDS has been a prominent point of research for life scientists around the world. With no current cure or vaccine available, scientists receive substantial amounts of funding to study this virus to gain a better understanding of it as well as to produce a vaccine that will combat the virus better than current treatments do, which can only slow and control the virus, but not cure it.